Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipine as a Disease Modifying Agent in Subjects With Early Parkinson Disease Phase 3 Double-blind Placebo-controlled Parallel Group Study of Isradipineas a Disease Modifying Age ...
National Institute of Neurological Disorders and Stroke (NINDS);Michael J. Fox Foundation for Parkinson's Research;The Parkinson Study Group National Institute of Neurological Disorders and Stroke (NINDS);Michael J. Fox Foundation for Parkin ...
Safety, Tolerability and Efficacy Assessment of Dynacirc CR in Parkinson Disease
A Pilot Phase II Double-Blind, Placebo-Controlled, Tolerability and Dosage Finding Study of Isradipine CR as a Disease Modifying Agent in Patients With Early Parkinson Disease A Pilot Phase II Double-Blind, Placebo-Controlled, Tolerability and Dosage Finding Study of Isradipi ...
Michael J. Fox Foundation for Parkinson's Research;Northwestern University Dixon Fund;The Parkinson Study Group Michael J. Fox Foundation for Parkinson's Research;Northwestern University Dixon Fund;The Parkinson ...
Phase II Safety and Tolerability of Isradipine (A Potential Neuroprotective Agent) in Patients With Parkinson's Disease- Stage II Phase II Safety and Tolerability of Isradipine(A Potential Neuroprotective Agent) in Patients With P ...